The Adult ADHD Quality Measures Initiative
Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA. J of Attention Disorder 2018:1-16
Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA. J of Attention Disorder 2018:1-16
Goodman DW, Starr LH, Yi-Wen M, Rostain AL, Ascher S. Armstron RB. J ClinPsychiatry 2017;78(1):105-114.
Goodman DW. Mental Disorders in Primary Care: A Guide to Evaluation and Management. Oxford Press. 2017. Chapter authored in (Carvalho AF, McIntrye RS)
Surman C, Goodman DW. ADHD Atten Def Hyp Disord. Jan2017.
Young J, Goodman DW. Primary Care Companion CNS Disord. 2016,18(6)
Goodman DW, Adler LA. Medscape, September 2016. CME accredited
ADHD in adults has now been recognized by clinicians for many years now. However, ADHD in older adults has received almost no attention because research has limited its work to those people under the age of 50. There is a body of research developing in older adults and I recently published with my colleagues a review of world-wide english published literature.
National Public Radio had the foresight to understand that this population of older adults with ADHD needs acknowledgement with a call to attention for their need for evaluation and treatment. To that end, they developed a broadcast with my assistance.
I invite you to listen/read both the audio and web text version are now available to the public. We can no longer discount the consequential negative impact of untreated ADHD on your parents and grandparents.
David W. Goodman, M.D.
On December 16, 2015, our article reviewing the world’s English scientific literature on ADHD in adults over age 50 years was published online in Drugs and Aging, an international journal. While there is a paucity of research, there are enough publications to merit pulling this literature together into one paper. Most of research comes out of the Amsterdam ADHD research group under the direction of Dr. Sandra Kooji. Some preliminary findings:
Our paper reviews a broader range of findings and will be helpful to researchers and clinicians seeking to broaden their knowledge and polish their clinical skills as these patients present for evaluation of cognitive complaints. We look forward to participating in the expansion of this knowledge.
David W. Goodman, M.D.
Goodman DW, Mitchell S, Rhodewalt L, Surman CBH. Drugs and Aging. Dec 2015. p1-10.
Although previously considered a disorder of childhood, studies in the last decade have demonstrated that attention-deficit hyperactivity disorder (ADHD) continues to impair function into adulthood and responds to pharmacotherapy. Due to age-specific changes in roles and challenges, it is possible that presentation and response to intervention may differ between older and younger adults. A literature search for papers that identified older adults with ADHD, including papers describing its epidemiology, manifestation, and treatment, was the basis for this paper. There is a paucity of data on ADHD in older adults; however, small observational studies have characterized the presence, impact, and treatment of ADHD in adults over the age of 50 years, and larger epidemiologic studies have demonstrated that ADHD symptoms exist in older adulthood. Optimal criteria for diagnosis of ADHD and methods of treating ADHD in older individuals have not been systematically explored. In light of the limited data, this review discusses considerations for differential diagnosis and safe pharmacotherapy of ADHD in older adults.
[button size=’large’ color=’btn-b76lpc214h’ link=’https://link.springer.com/article/10.1007/s40266-015-0327-0?wt_mc=internal.event.1.SEM.ArticleAuthorOnlineFirst’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Goodman DW. Mental Illness in Primary Care. Oxford Press. 2015. (book chapter)